News

A study in JAMA Pediatrics suggests that infants exposed to Zika in utero who do not show signs of congenital Zika syndrome may still be at risk for abnormal neurodevelopmental outcomes.

A new article in Open Forum Infectious Diseases outlines practical strategies for treating opioid use disorder in the context of associated infectious diseases.

A new study is shedding light on how bioburden and patient colonization play off each other.

Viral suppression at 2 years nearly doubled for people with HIV in a medical care coordination program implemented by the Los Angeles County Division of HIV and STD Programs, a new study found.

Earlier initiation of DAP-CPT combination therapy may be beneficial, despite a tendency to use the therapy after initial treatment failure.

In a head-to-head comparison, investigators found that 3 enhanced flu vaccines provided better protection for elderly patients compared to standard-dose vaccines.

Women and adults aged 65 or older were particularly affected by the increased incidence of nontuberculous mycobacterial (NTM) lung disease infections.

We are taking a look back at the top articles published in Contagion®’s print journal in 2019.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 29, 2019.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Treating parents colonized with S aureus reduced neonatal colonization with concordant S aureus strains when compared to placebo.

According to a new report issued by the WHO, the global incidence of cholera cases decreased by 60% in 2018.

A new study published in the Journal of Clinical Investigation may offer some insight on why past efforts to develop a vaccine for S aureus have failed.

The Bacille Calmette-Geurin vaccine is typically administered intradermally, which may not generate enough T cells to elicit strong immune responses in the lungs to effectively protect against TB.

Exploring the antibiotic commercial conundrum. ​

The CDC MMWR provides a summary of the Ebola response from August 2018 to November 2019, noting 2196 deaths and consistent challenges in outbreak control due to government mistrust and ongoing armed conflict.

Investigators of a new, multisite study evaluating neuropsychological development in African school-age kids found that children with perinatally-acquired HIV had poorer results on neuropsychological tests despite early ART initiation and viral suppression.

A recent study published in Transgender Health analyzed transgender and gender-nonconforming ART adherence based on the US Trans Survey, the largest survey of TGNC people in the United States.

As December draws to a close, the Contagion® editorial team is recapping the trends and top infectious disease news of the month.

Stay up-to-date on the top infectious disease news by checking out our top 5 articles of the year.

Even as hospitals try to stop health care-associated illnesses, they can often have difficulty identifying which employees are too sick to work. New research suggests a high number of health care employees work while experiencing symptoms of illness.

A recent commentary discusses the need to uncover diagnostic and prognostic biomarkers for HIV-associated neurocognitive disorder (HAND).

Here is a look back at approvals, clearances, and authorizations granted by the US Food and Drug Administration for infectious disease products in 2019.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 22, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

A study sheds light on the challenges we need to account for in treating neglected tropical diseases.

Contagion® counts down the top HIV news stories of 2019, including FDA approvals, breakthrough discoveries, recommendations from the frontlines, and a big-picture look at just how close we are to ending the epidemic.

A new study out of Africa demonstrates that maternal-child clinics may act as a one-stop shop for both pregnancy and postpartum concerns and HIV protection.